⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XERS News
Xeris Biopharma Holdings, Inc. Common Stock
Form 8-K
sec.gov
XERS
Form 8-K
sec.gov
XERS
Xeris Biopharma to Report First Quarter 2026 Financial Results on May 7, 2026
businesswire.com
XERS
Form 8-K
sec.gov
XERS
Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
businesswire.com
XERS
Periodic Paralysis Association Marks World Periodic Paralysis Day on March 23, Urging Faster Diagnosis and First-Ever Dedicated Research Funding
businesswire.com
XERS
Form 8-K
sec.gov
XERS
Xeris Biopharma Reports Record Performance for Fourth Quarter and Full Year 2025 and Provides Full Year 2026 Guidance
businesswire.com
XERS
Form 8-K
sec.gov
XERS
Xeris Biopharma Subsidiaries File Recorlev ® Patent Infringement Lawsuit
businesswire.com
XERS